Tactile Systems Technology Inc (TCMD)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $23.91
- As of
Kresmion compiles this page from TCMD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
TACTILE SYSTEMS TECHNOLOGY INC (TCMD): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-10.
See the full TCMD dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for TCMD on one page. Preview it with sample data, then open it live with a free account.
Preview the TCMD dossierActive events for TCMD
- high13F: large increase
CITADEL ADVISORS LLC added +155% to TCMD (2026Q2)
- mediumEarnings above estimates
Q2-2026: Beat consensus by 131.4%, EPS $0.34 vs $0.1469 estimate
- mediumEarnings above estimates
Q2-2025: Beat consensus by 27.0% - EPS $0.14 vs $0.1102 estimate
- mediumEarnings above estimates
Q3-2025: Beat consensus by 102.8% - EPS $0.36 vs $0.1775 estimate
- mediumEarnings above estimates
Q1-2026: Beat consensus by 16.6% - EPS $-0.08 vs $-0.0959 estimate
FREE, NO ACCOUNT
Every event on TCMD, as it fires
New filings, 13F moves and cross asset events on TCMD land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in TCMD (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 87357P100 · 2026Q2 | $14.1M | 0.02% | , |
| D. E. Shaw & Co., Inc.CUSIP 87357P100 · 2026Q2 | $5.5M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 87357P100 · 2026Q2 | $1.7M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 87357P100 · 2026Q2 | $1.4M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, TCMD
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
TCMD against its peers
TCMD's operating margin of 8.9% ranks in the 93rd percentile of 22 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2025-12-31.
| Metric | TCMD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 330M USD | 122M USD | 72 | 22 |
| Gross margin | 75.9% | 61.4% | 66 | 21 |
| Operating margin | 8.9% | -22.4% | 93 | 22 |
| Net margin | 5.8% | -24.6% | 89 | 22 |
| Return on equity | 8.7% | -25.5% | 80 | 21 |
| P / E | 29.2x | 46.2x | 42 | 5 |
Peers (22): DCTH, SSII, MASS, RCEL, KIDS, NPCE, OFIX, SENS, VMD, CV, INMD, IART, QSI, QDEL, SIBN, CLPT, TMCI, INFU, BBNX, CBLL, AORT, AVNS.D. Left out: BWAY (period gap), MOBI (no annual filing), LMRI (no annual filing). Fiscal periods ending between 2025-12-28 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (TCMD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow TCMD on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to TCMD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.